CN109350316B - A kind of vascular stent monomer and vascular stent - Google Patents
A kind of vascular stent monomer and vascular stent Download PDFInfo
- Publication number
- CN109350316B CN109350316B CN201811315239.2A CN201811315239A CN109350316B CN 109350316 B CN109350316 B CN 109350316B CN 201811315239 A CN201811315239 A CN 201811315239A CN 109350316 B CN109350316 B CN 109350316B
- Authority
- CN
- China
- Prior art keywords
- vascular stent
- base
- edges
- stent
- edge
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
Description
技术领域Technical field
本发明涉及医疗器械技术领域,特别是涉及一种血管支架单体及血管支架。The present invention relates to the technical field of medical devices, and in particular to a vascular stent monomer and a vascular stent.
背景技术Background technique
在血管支架手术中,在病变段置入内支架以达到支撑狭窄闭塞段血管,减少血管弹性回缩及再塑形,和保持管腔血流通畅的目的。现有技术方案中,早期的金属支架应用临床治疗后取得了令人瞩目的疗效,但其易导致血栓形成,再狭窄率高,且会造成血管壁损伤。而新研制开发出的覆膜支架及生物材料支架属于可降解材料,其刚度等力学性能明显不足,会导致可降解支架植入狭窄血管后,在其动态服役过程中因支撑性能不足导致血管再次缩小。大部分支架扩张时,支撑体沿着周向变形使支架轴向尺寸变短,轴向短缩率较高。另外,现有血管支架并不能减小血液流动时对血管壁的压力。In vascular stent surgery, an internal stent is placed in the diseased segment to support the narrowed and occluded segment of the blood vessel, reduce elastic recoil and reshaping of the blood vessel, and maintain smooth blood flow in the lumen. Among the existing technical solutions, early metal stents have achieved remarkable results after being used in clinical treatments, but they can easily lead to thrombosis, have a high restenosis rate, and cause damage to the blood vessel wall. The newly developed covered stents and biomaterial stents are degradable materials, and their mechanical properties such as stiffness are obviously insufficient, which will cause the degradable stent to be implanted in a narrow blood vessel and cause the blood vessel to collapse again due to insufficient support performance during its dynamic service. Zoom out. When most stents are expanded, the support body deforms along the circumferential direction, shortening the axial dimension of the stent, and the axial shortening rate is high. In addition, existing vascular stents cannot reduce the pressure on the blood vessel wall when blood flows.
发明内容Contents of the invention
本发明的目的在于避免现有技术中的血管支架力学性能不足和不能减小血液流动时对血管壁的压力的问题,而提供一种血管支架单体及血管支架以实现对血管稳定的支撑,减小血管再缩小率和减小血液流动时对血管壁的压力。The purpose of the present invention is to avoid the problems of insufficient mechanical properties of blood vessel stents in the prior art and the inability to reduce the pressure on the blood vessel wall during blood flow, and to provide a blood vessel stent monomer and a blood vessel stent to achieve stable support for blood vessels. Reduce the re-narrowing rate of blood vessels and reduce the pressure on the blood vessel wall during blood flow.
本发明的目的通过以下技术方案实现:The object of the present invention is achieved through the following technical solutions:
一种血管支架单体,其包括a底面、b底面与棱边,所述a底面与所述b底面相互平行,所述a底面与所述b底面均为多边形且由所述多边形的各边组成,所述a底面在所述b底面的投影被包含于所述b底面内,所述a底面上的顶点通过所述棱边连接所述b底面上相近的顶点,所述a底面及所述b底面上的每个顶点均有且只有一条所述棱边与其连接,所述棱边包括Y形棱边。A vascular stent monomer, which includes a bottom surface, a bottom surface b and an edge. The bottom surface a and the bottom surface b are parallel to each other. Both the bottom surface a and the bottom surface b are polygons and are formed by each side of the polygon. Composition, the projection of the bottom surface a on the bottom surface b is included in the bottom surface b, the vertices on the bottom surface a are connected to the adjacent vertices on the bottom surface b through the edges, the bottom surface a and the bottom surface b are Each vertex on the bottom surface of b has and has only one edge connected thereto, and the edge includes a Y-shaped edge.
优选地,所述a底面与所述b底面为不规则且不同边数的多边形,或所述a底面与所述b底面为规则且不同边数的多边形。Preferably, the bottom surface a and the bottom surface b are irregular polygons with different numbers of sides, or the bottom surface a and the bottom surface b are regular polygons with different numbers of sides.
优选地,所述a底面与所述b底面,一个为规则多边形,另一个为不规则多边形。Preferably, one of the bottom surface a and the bottom surface b is a regular polygon, and the other is an irregular polygon.
优选地,所述a底面与所述b底面,一个为五边形,另一个为六边形,所述棱边包括一条Y形棱边和四条直棱边。Preferably, one of the bottom surface a and the bottom surface b is a pentagon and the other is a hexagon, and the edges include a Y-shaped edge and four straight edges.
优选地,所述a底面为正五边形,所述b底面为六边形且为非正六边形。Preferably, the bottom surface a is a regular pentagon, and the bottom surface b is a hexagon and is not a regular hexagon.
优选地,所述a底面与所述b底面的各边为圆柱体,所述棱边均为圆柱体,所述棱边为直棱边或弧棱边,所述棱边包括至少2条所述Y形棱边。Preferably, each edge of the bottom surface a and the bottom surface b is a cylinder, the edges are all cylinders, the edges are straight edges or arc edges, and the edges include at least 2 of them. Describe the Y-shaped edge.
优选地,所述a底面的几何中心在所述b底面的投影与所述b底面的几何中心重合,所述a底面的面积不小于所述b底面的面积的二分之一。Preferably, the projection of the geometric center of the bottom surface a on the bottom surface b coincides with the geometric center of the bottom surface b, and the area of the bottom surface a is not less than half of the area of the bottom surface b.
一种血管支架,其由若干个上述的血管支架单体衔接而成,除了分别处于所述血管支架的头尾的两个血管支架单体外,任一血管支架单体的所述a底面都与另一个血管支架单体的所述a底面接合,任一血管支架单体的所述b底面也与另一个血管支架单体的所述b底面接合。A vascular stent, which is formed by connecting several of the above-mentioned vascular stent monomers. Except for the two vascular stent monomers located at the head and tail of the vascular stent, the bottom surface a of any vascular stent monomer is The bottom surface a of another vascular stent unit is joined to the bottom surface b of any vascular stent unit. The bottom surface b of any vascular stent unit is also joined to the bottom surface b of another vascular stent unit.
优选地,所述血管支架是由非晶材料制作的支架,其外表覆以聚合物薄膜,其表面涂以药物涂层以用于降低血栓形成和新生内膜增生的风险。Preferably, the vascular stent is a stent made of amorphous material, its outer surface is covered with a polymer film, and its surface is coated with a drug coating to reduce the risk of thrombosis and neointimal hyperplasia.
优选地,所述血管支架是由锆基非晶材料制作的支架。Preferably, the vascular stent is a stent made of zirconium-based amorphous material.
本发明的有益效果:Beneficial effects of the present invention:
本血管支架单体的结构满足支撑血管壁所需的力学条件,其结构能在支架受到血管壁挤压力时仍保持足够的结构稳定性,其中Y形棱边是支架在变形时发挥主要稳定作用的结构。The structure of this vascular stent alone meets the mechanical conditions required to support the blood vessel wall. Its structure can still maintain sufficient structural stability when the stent is squeezed by the blood vessel wall. The Y-shaped edge is the main stabilizing force of the stent when it is deformed. The structure of action.
另外,根据流体连续性方程和伯努利方程,血液在流经本血管支架的过程中,血液的流速在血管支架单体局部半径变小的部位会升高,因此血液对血管壁的压力随之下降。当血管壁适应性生长贴合到血管支架外表面时,或血管支架外侧形成血栓后,这种伯努利效应会更加明显。在血管支架内,连续的血管支架单体产生的作用有利于减小血液流动时对血管壁的压力,能够降低动脉瘤增大和破裂的风险。In addition, according to the fluid continuity equation and Bernoulli's equation, during the process of blood flowing through the vascular stent, the flow rate of the blood will increase at the location where the local radius of the vascular stent becomes smaller, so the pressure of the blood on the blood vessel wall will increase as the local radius of the vascular stent becomes smaller. of decline. This Bernoulli effect will be more obvious when the adaptive growth of the blood vessel wall adheres to the outer surface of the vascular stent, or when thrombus forms on the outside of the vascular stent. In the vascular stent, the effect of the continuous vascular stent monomer is beneficial to reducing the pressure on the blood vessel wall during blood flow, which can reduce the risk of aneurysm growth and rupture.
本发明避免了现有技术中的血管支架力学性能不足和不能减小血液流动时对血管壁的压力的问题,提出一种血管支架单体及血管支架以实现对血管稳定的支撑,减小血管再缩小率和减小血液流动时对血管壁的压力,能够降低动脉瘤增大和破裂的风险。The present invention avoids the problems of insufficient mechanical properties of blood vessel stents in the prior art and the inability to reduce the pressure on the blood vessel wall during blood flow. It proposes a blood vessel stent monomer and a blood vessel stent to achieve stable support for blood vessels and reduce blood vessel wall stress. The rate of re-narrowing and reducing the pressure on the vessel wall as blood flows reduces the risk of the aneurysm growing and rupturing.
附图说明Description of the drawings
利用附图对发明作进一步说明,但附图中的实施例不构成对本发明的任何限制,对于本领域的普通技术人员,在不付出创造性劳动的前提下,还可以根据以下附图获得其它的附图。The invention is further described using the accompanying drawings, but the embodiments in the accompanying drawings do not constitute any limitation to the invention. For those of ordinary skill in the art, without exerting creative efforts, other embodiments can be obtained based on the following drawings. Picture attached.
图1是本发明的一种血管支架的结构示意图。Figure 1 is a schematic structural diagram of a vascular stent of the present invention.
图2是本发明的一种血管支架单体的结构示意图。Figure 2 is a schematic structural diagram of a single vascular stent of the present invention.
图中包括:棱边1、血管支架单体2、b底面3、a底面4、Y形棱边5、血管支架6。The figure includes: edge 1, vascular stent unit 2, b bottom surface 3, a bottom surface 4, Y-shaped edge 5, and vascular stent 6.
具体实施方式Detailed ways
结合以下实施例对本发明作进一步描述。The present invention will be further described in conjunction with the following examples.
如图1至图2所示,本实施例的一种血管支架单体2,其包括a底面4、b底面3与棱边1,所述a底面4与所述b底面3相互平行,所述a底面4与所述b底面3均为多边形且由所述多边形的各边组成,所述a底面4在所述b底面3的投影被包含于所述b底面3内,所述a底面4上的顶点通过所述棱边1连接所述b底面3上相近的顶点,所述a底面4及所述b底面3上的每个顶点均有且只有一条所述棱边1与其连接,所述棱边1包括Y形棱边5。As shown in Figures 1 to 2, a vascular stent unit 2 in this embodiment includes a bottom surface 4, a bottom surface 3 and an edge 1. The bottom surface a 4 and the bottom surface b 3 are parallel to each other, so Both the bottom surface a 4 and the bottom surface b 3 are polygons and are composed of each side of the polygon. The projection of the bottom surface a 4 on the bottom surface b 3 is included in the bottom surface b 3 . The bottom surface a The vertices on 4 are connected to the adjacent vertices on the bottom surface b 3 through the edge 1. Each vertex on the bottom surface a 4 and the bottom surface b 3 has one and only one edge 1 connected to it, The edge 1 includes a Y-shaped edge 5 .
本血管支架单体2的结构满足支撑血管壁所需的力学条件,其结构能在支架受到血管壁挤压力时仍保持足够的结构稳定性,其中Y形棱边5是支架在变形时发挥主要稳定作用的结构。The structure of the vascular stent monomer 2 meets the mechanical conditions required to support the blood vessel wall, and its structure can maintain sufficient structural stability when the stent is subjected to the extrusion force of the blood vessel wall. The Y-shaped edge 5 is the stent's function when deformed. Mainly stabilizing structure.
优选地,所述a底面4为正五边形,所述b底面3为六边形且为非正六边形,所述棱边1包括一条Y形棱边5和四条弧棱边1。这种结构有利于使血管支架单体2形成更好的结构稳定性。Preferably, the bottom surface a 4 is a regular pentagon, the bottom surface b 3 is a hexagon and is not a regular hexagon, and the edge 1 includes a Y-shaped edge 5 and four arc edges 1 . This structure is conducive to forming better structural stability of the vascular stent monomer 2 .
优选地,所述a底面4与所述b底面3的各边为圆柱体,所述棱边1均为圆柱体,这样的形状有利于避免血管支架单体2对血管壁造成损伤。所述棱边1为弧棱边以满足某些特殊形状和角度要求。所述棱边1包括至少2条所述Y形棱边5,以利于血管支架单体2形成更好的结构稳定性。Preferably, each side of the bottom surface a 4 and the bottom surface b 3 is a cylinder, and the edges 1 are all cylinders. Such a shape is beneficial to avoid damage to the blood vessel wall caused by the vascular stent unit 2 . The edge 1 is an arc edge to meet certain special shape and angle requirements. The edge 1 includes at least two Y-shaped edges 5 to facilitate the formation of better structural stability of the vascular stent monomer 2 .
优选地,所述a底面4的几何中心在所述b底面3的投影与所述b底面3的几何中心重合,所述a底面4的面积不小于所述b底面3的面积的二分之一,使得血管支架单体2形成更利于支撑血管的结构。Preferably, the projection of the geometric center of the bottom surface a 4 on the bottom surface b 3 coincides with the geometric center of the bottom surface b 3 , and the area of the bottom surface a 4 is not less than half of the area of the bottom surface b 3 . First, the vascular stent monomer 2 forms a structure that is more conducive to supporting blood vessels.
本实施例还包括一种血管支架6,其由若干个上述的血管支架单体2衔接而成,除了分别处于所述血管支架6的头尾的两个血管支架单体2外,任一血管支架单体2的所述a底面4都与另一个血管支架单体2的所述a底面4接合,任一血管支架单体2的所述b底面3也与另一个血管支架单体2的所述b底面3接合。This embodiment also includes a vascular stent 6, which is composed of several of the above-mentioned vascular stent monomers 2. Except for the two vascular stent monomers 2 respectively located at the head and tail of the vascular stent 6, any blood vessel stent 6 The a bottom surface 4 of the stent unit 2 is connected to the a bottom surface 4 of another vascular stent unit 2, and the b bottom surface 3 of any vascular stent unit 2 is also connected to the a bottom surface 4 of another vascular stent unit 2. The b bottom surface 3 is joined.
根据流体连续性方程和伯努利方程,血液在流经本血管支架6的过程中,血液的流速在血管支架单体2局部半径变小的部位会升高,因此血液对血管壁的压力随之下降。当血管壁适应性生长贴合到血管支架6外表面时,或血管支架6外侧形成血栓后,这种伯努利效应会更加明显。在血管支架6内,连续的血管支架单体2产生的作用有利于减小血液流动时对血管壁的压力,能够降低动脉瘤增大和破裂的风险。According to the fluid continuity equation and Bernoulli's equation, during the process of blood flowing through the vascular stent 6, the flow rate of the blood will increase at the location where the local radius of the vascular stent monomer 2 becomes smaller, so the pressure of the blood on the blood vessel wall increases as the local radius of the vascular stent 2 becomes smaller. of decline. This Bernoulli effect will be more obvious when the blood vessel wall grows adaptively and adheres to the outer surface of the blood vessel stent 6 , or when thrombus forms on the outside of the blood vessel stent 6 . In the vascular stent 6, the continuous vascular stent monomer 2 has the effect of reducing the pressure on the blood vessel wall during blood flow, and can reduce the risk of aneurysm enlargement and rupture.
优选地,所述血管支架外表覆以聚合物薄膜以用于承载药物,其表面涂以药物涂层以降低支架植入后血栓形成和新生内膜增生风险。Preferably, the vascular stent is coated with a polymer film for carrying drugs, and the surface is coated with a drug coating to reduce the risk of thrombosis and neointimal hyperplasia after stent implantation.
优选地,所述血管支架是由锆基非晶材料制作的支架。锆基非晶合金材料具有高的抗拉强度、高的弹性能、高的冲击断裂性能、高的耐腐蚀性能、好的延展性、优异的固有低频振动阻尼性能、高的电催化活性, 高的生物亲和性,添加铁后具有良好的磁性能,在血管复杂内环境中的动态服役过程中具有良好的稳定性。由锆基非晶合金材料制作的血管支架6有利于避免血栓形成,再狭窄率高,造成血管壁损伤的问题,及解决当支架扩张时支架轴向尺寸变短,轴向短缩率较高的问题。Preferably, the vascular stent is a stent made of zirconium-based amorphous material. Zirconium-based amorphous alloy materials have high tensile strength, high elastic energy, high impact fracture performance, high corrosion resistance, good ductility, excellent inherent low-frequency vibration damping performance, high electrocatalytic activity, and high It has good bioaffinity, good magnetic properties after adding iron, and good stability during dynamic service in the complex internal environment of blood vessels. The vascular stent 6 made of zirconium-based amorphous alloy material is beneficial to avoid thrombosis, high restenosis rate and damage to the blood vessel wall, and solves the problem of shortening of the stent's axial dimension and high axial shortening rate when the stent is expanded. The problem.
本实施例避免了现有技术中的血管支架力学性能不足和不能减小血液流动时对血管壁的压力的问题,提出一种血管支架单体及血管支架以实现对血管稳定的支撑,减小血管再缩小率和减小血液流动时对血管壁的压力,能够降低动脉瘤增大和破裂的风险。This embodiment avoids the problems of insufficient mechanical properties of blood vessel stents in the prior art and the inability to reduce the pressure on the blood vessel wall during blood flow. It proposes a blood vessel stent monomer and a blood vessel stent to achieve stable support for blood vessels and reduce the pressure on the blood vessel wall. The rate of re-narrowing of blood vessels and reducing the pressure on the vessel wall as blood flows reduces the risk of aneurysm growth and rupture.
最后应当说明的是,以上实施例仅用以说明本发明的技术方案,而非对本发明保护范围的限制,尽管参照较佳实施例对本发明作了详细地说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的实质和范围。Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention and are not intended to limit the scope of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those of ordinary skill in the art will understand that , the technical solution of the present invention may be modified or equivalently substituted without departing from the essence and scope of the technical solution of the present invention.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811315239.2A CN109350316B (en) | 2018-11-06 | 2018-11-06 | A kind of vascular stent monomer and vascular stent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811315239.2A CN109350316B (en) | 2018-11-06 | 2018-11-06 | A kind of vascular stent monomer and vascular stent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN109350316A CN109350316A (en) | 2019-02-19 |
| CN109350316B true CN109350316B (en) | 2024-03-12 |
Family
ID=65344318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811315239.2A Active CN109350316B (en) | 2018-11-06 | 2018-11-06 | A kind of vascular stent monomer and vascular stent |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109350316B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109925104B (en) * | 2019-04-29 | 2020-11-17 | 哈尔滨工业大学 | Novel truss type human body pipeline bracket |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5507771A (en) * | 1992-06-15 | 1996-04-16 | Cook Incorporated | Stent assembly |
| US5800393A (en) * | 1997-03-07 | 1998-09-01 | Sahota; Harvinder | Wire perfusion catheter |
| CN209316165U (en) * | 2018-11-06 | 2019-08-30 | 广东工业大学 | A kind of vascular stent monomer and vascular stent |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030135268A1 (en) * | 2000-04-11 | 2003-07-17 | Ashvin Desai | Secure stent for maintaining a lumenal opening |
| US9333102B2 (en) * | 2003-02-24 | 2016-05-10 | Allium Medical Solutions Ltd. | Stent |
| DE102007019058A1 (en) * | 2007-04-23 | 2008-10-30 | Stengel, Max, Dr.Dr. | Vascular implant for the treatment of an aneurysm |
| US20090287293A1 (en) * | 2008-05-15 | 2009-11-19 | Mailhot Jr Robert | Magnetically induced radial expansion vascular stent |
-
2018
- 2018-11-06 CN CN201811315239.2A patent/CN109350316B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5507771A (en) * | 1992-06-15 | 1996-04-16 | Cook Incorporated | Stent assembly |
| US5800393A (en) * | 1997-03-07 | 1998-09-01 | Sahota; Harvinder | Wire perfusion catheter |
| CN209316165U (en) * | 2018-11-06 | 2019-08-30 | 广东工业大学 | A kind of vascular stent monomer and vascular stent |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109350316A (en) | 2019-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110731843A (en) | a vascular stent | |
| CN107847232A (en) | Devices used to occlude the auricle | |
| CN204951247U (en) | Biodegradable metal blood vessel support | |
| US20200383769A1 (en) | Luminal Stent | |
| JP2016508852A (en) | Expandable embedded conduit | |
| CN102743241B (en) | Novel deformable non-axial flow vena cava filter | |
| WO2017012386A1 (en) | Biodegradable metal vascular scaffold and use thereof | |
| US20140012366A1 (en) | Stent | |
| CN104306040B (en) | Left atrial appendage plugging device | |
| WO2018036434A1 (en) | Implant-type, completely bioabsorbable, vascular polymer stent | |
| CN108670509A (en) | A kind of self-expansion type taper coronary stent | |
| CN109350316B (en) | A kind of vascular stent monomer and vascular stent | |
| CN106236342B (en) | Implantable complete biological absorbable vascular polymer stent | |
| CN113456290B (en) | Degradable metal skull repairing mesh implant | |
| CN106880429A (en) | A kind of spiral intravascular stent | |
| CN107174376A (en) | A kind of arteria covering membrane supporter | |
| WO2022100715A1 (en) | Valve stent and valve prosthesis | |
| CN209316165U (en) | A kind of vascular stent monomer and vascular stent | |
| CN204158523U (en) | Dissecting aneurysm of aorta overlay film frame | |
| CN105726178B (en) | A kind of intravascular stent, its preparation method and application | |
| CN110613540A (en) | Blood vessel implantation stent | |
| CN203988521U (en) | A kind of asymmetric conical intravascular stent | |
| CN207168613U (en) | A kind of intravascular stent | |
| CN212940079U (en) | A new type of vascular stent | |
| CN206777427U (en) | A kind of complete biological absorbable blood vessel polymer support of implanted |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |